Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Mayinglong Pharmaceutical Group Co Ltd
Pre-Tax Income
Mayinglong Pharmaceutical Group Co Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
Pre-Tax Income
¥583m
|
CAGR 3-Years
8%
|
CAGR 5-Years
21%
|
CAGR 10-Years
10%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Pre-Tax Income
¥3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Pre-Tax Income
¥3.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Pre-Tax Income
¥4.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
11%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Pre-Tax Income
¥4.8B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Pre-Tax Income
¥891.8m
|
CAGR 3-Years
35%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
See Also
What is Mayinglong Pharmaceutical Group Co Ltd's Pre-Tax Income?
Pre-Tax Income
583m
CNY
Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Pre-Tax Income amounts to 583m CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
10%
Over the last year, the Pre-Tax Income growth was -3%. The average annual Pre-Tax Income growth rates for Mayinglong Pharmaceutical Group Co Ltd have been 8% over the past three years , 21% over the past five years , and 10% over the past ten years .